Search bioRxiv⌕ Search

Biology subjects

Laguia, F.

Publications and source records attributed to Laguia, F..

3 recordsLinked to original sources

Human CD34⁺ progenitor-derived DC2 and DC3 subsets support CD169-mediated HIV-1 uptake

Dendritic cells (DCs) are central orchestrators of antiviral immunity but can be exploited by HIV-1 to facilitate systemic dissemination. HIV-1 recognition by CD169 triggers massive endocytosis (MEND)-related internalization of viral particles into sac-like compartments in monocyte-derived dendritic cells (MDDCs), thereby promoting trans-infection of CD4+ T cells. However, MDDCS represent only one DC subpopulation, and whether other physiologically relevant DC subsets exhibit similar behavior remains unclear. Moreover, endogenous CD169 expression and viral capture have not been fully characterized in cDC1, DC2, or pDCs, while remain unknown in DC3. We therefore investigated the contribution of these DC subsets to CD169-mediated HIV-1 capture and subsequent viral dissemination. We used flow cytometry to assess CD169 expression and viral capture across DC subsets differentiated from CD34 hematopoietic stem and progenitor cells (HSPC) obtained from bone marrow (BM) and cord blood (CB), two sources that differ in cellular maturity. Confocal microscopy was used to evaluate sac-like compartment formation following immune activation with IFN- or LPS and treatment with MEND inhibitors. Trans-infection capacity was quantified by measuring luciferase activity in TZM-bl reporter cells. We identified cDC1, DC2, DC3, moDC (similar to MDDCs), and pDC subsets following the differentiation of CD34 HSPC from both CB and BM. Among these populations, DC2, DC3, and moDC displayed high CD169 expression, which was significantly upregulated by IFN- or LPS stimulation. BM-derived DCs exhibited higher basal CD169 expression than CB-derived DCs, whereas stimulation induced greater CD169 upregulation in CB-derived DCs. DC2, DC3, and moDC efficiently captured HIV-1 particles in cultures derived from both sources, and viral uptake was further enhanced by immune activation. Viral internalization into sac-like compartments depended on CD169 binding and MEND-related mechanisms, ultimately facilitating HIV-1 transfer to target cells. DC2 and DC3 are key dendritic cell subsets that support CD169 dependent HIV-1 capture and are associated with MEND-driven internalization into sac-like compartments and subsequent viral transfer to target cells, as was previously described for moDCs. We further observed distinct basal and inducible CD169 expression profiles in BM- and CB-derived DCs, consistent with source-dependent maturation states. These results identify DC2 and DC3 as key cellular contributors to HIV-1 dissemination.

immunology↗

Humanized FLT3 mice display enhanced tissue engraftment and support HIV-1 persistence and rebound

Despite advances in antiretroviral therapy (ART), HIV-1 cure efforts remain hindered by viral reservoirs in long-lived myeloid cells and immune-privileged tissues that are less accessible and therefore unlikely to be assessed in human clinical trials. Consequently, there is a critical need for robust research platforms such as immune cell humanized mice to bridge preclinical and clinical HIV research. However, previously described humanized mouse models have demonstrated incomplete hematopoietic development, particularly showing low levels of NK or myeloid cells. Herein, we present the novel humanized FLT3 mouse model that develops NK cells, myeloid progenitors, monocytes, and both functional conventional (cDCs) and plasmacytoid dendritic cells (pDCs) to support HIV-1 infection. Human cord blood derived CD34+ hematopoietic stem cells (HSC) were engrafted in the FLT3 (Hu-FLT3) and NSG (Hu-NSG) mouse strains for comparison. Our data showed that while Hu-NSG and Hu-FLT3 mice have comparable human lymphocyte levels, the proportion of myeloid cells (including monocytes, pDCs and cDCs) in Hu-FLT3 mice (16.2 %) was three-fold higher than in Hu-NSG mice (5.6 %) and the proportion of NK cells was six-fold higher (12.8 % and 1.9 %, respectively). Both strains successfully supported HIV-1 infection, maintain viral replication for 17 weeks in untreated mice, and proviral DNA was detectable in peripheral blood, bone marrow and spleen. While ART effectively reduced viral load to undetectable levels in four weeks in both strains, we observed viral rebound after treatment discontinuation within 3 weeks, reaching the same levels of viral load pre-ART and mimicking what is observed in people living with HIV (PLWH).Human immune cells and HIV-1 RNA were higher in tissues of Hu-FLT3 mice compared to Hu-NSG mice, mirroring features reported in human tissue reservoirs. Our findings demonstrated that Hu-FLT3 mice support enhanced development of human innate immune cells in blood and tissues, which are associated with higher levels of HIV-1 replication compared to Hu-NSG mice. This study establishes a novel, robust and accessible in vivo platform to investigate potential HIV cure and persistence-targeting interventions with translational relevance to human therapeutic development thanks to the improved and more complete human immune repertoire in Hu-FLT3.

immunology↗

Pediatric Long COVID Is Characterized by Myeloid CCR6 Suppression and Immune Dysregulation

The biological mechanisms underlying long COVID in the pediatric population are poorly understood. Our study aimed to characterize the immune pathophysiology of long COVID in children and young people (CYP). We analyzed major immune cell compartments in PBMCs, as well as specific SARS-CoV-2 antibody response in CYP with (n=99) and without (n=18) long COVID at three months following acute infection. Our findings indicate that pediatric long COVID is associated with a dysregulated immune response characterized by altered innate immunity and overactivated T-, B- and NK-cell responses. Furthermore, CYP with long COVID had an impaired humoral response to SARS-CoV-2 marked by a dysregulated B-cell compartment and lower levels of anti-RBD IgG and IgA. This correlated with reduced neutralizing capacity against SARS-CoV-2. Random forest analysis identified CCR6 expression on myeloid cells as the most relevant biomarker that distinguishes long COVID from control individuals with 79% accuracy. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=154 SRC="FIGDIR/small/671713v1_ufig1.gif" ALT="Figure 1"> View larger version (32K): org.highwire.dtl.DTLVardef@1145480org.highwire.dtl.DTLVardef@1b7a635org.highwire.dtl.DTLVardef@fb13org.highwire.dtl.DTLVardef@63a49a_HPS_FORMAT_FIGEXP M_FIG C_FIG

immunology↗